Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 33 positions. The ten largest identified positions carry 56.8% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | Invesco Private Prime Fund | — | United States | 12.88% | $36.34M |
| 2 | Regeneron Pharmaceuticals, Inc. REGN | Healthcare | United States | 5.47% | $15.43M |
| 3 | Amgen Inc. AMGN | Healthcare | United States | 5.22% | $14.72M |
| 4 | CareDx, Inc. CDNA | Healthcare | United States | 5.04% | $14.21M |
| 5 | Vertex Pharmaceuticals Inc. VRTX | Healthcare | United States | 4.98% | $14.05M |
| 6 | Invesco Private Government Fund | — | United States | 4.96% | $14.00M |
| 7 | Royalty Pharma PLC RPRX |
Source: SEC filings. Information and analytics, not investment advice.
| Healthcare |
| United Kingdom |
| 4.94% |
| $13.93M |
| 8 | Biogen Inc. BIIB | Healthcare | United States | 4.78% | $13.49M |
| 9 | Gilead Sciences, Inc. GILD | Healthcare | United States | 4.43% | $12.50M |
| 10 | United Therapeutics Corp. UTHR | Healthcare | United States | 4.07% | $11.49M |
| 11 | Bio-Techne Corp. TECH | Healthcare | United States | 3.73% | $10.52M |
| 12 | Illumina, Inc. ILMN | Healthcare | United States | 3.50% | $9.89M |
| 13 | Protagonist Therapeutics, Inc. PTGX | Healthcare | United States | 3.39% | $9.57M |
| 14 | Vericel Corp. VCEL | Healthcare | United States | 3.26% | $9.20M |
| 15 | Alnylam Pharmaceuticals, Inc. ALNY | Healthcare | United States | 3.16% | $8.93M |
| 16 | Incyte Corp. INCY | Healthcare | United States | 3.05% | $8.62M |
| 17 | Repligen Corp. RGEN | Healthcare | United States | 3.04% | $8.57M |
| 18 | Acadia Pharmaceuticals Inc. ACAD | Healthcare | United States | 3.02% | $8.52M |
| 19 | Halozyme Therapeutics, Inc. HALO | Healthcare | United States | 2.98% | $8.41M |
| 20 | Qiagen N.V. QGEN | Healthcare | Netherlands | 2.89% | $8.15M |
| 21 | BioMarin Pharmaceutical Inc. BMRN | Healthcare | United States | 2.81% | $7.95M |
| 22 | Neurocrine Biosciences, Inc. NBIX | Healthcare | United States | 2.66% | $7.50M |
| 23 | Exelixis, Inc. EXEL | Healthcare | United States | 2.63% | $7.43M |
| 24 | BioCryst Pharmaceuticals, Inc. BCRX | Healthcare | United States | 2.63% | $7.42M |
| 25 | Veracyte, Inc. VCYT | Healthcare | United States | 2.60% | $7.33M |